Activity value 87International Buyer&Supplier,Last transaction date:
2026-06-09Address: belgica,rixensart,rue de i┤insititut, 89 b-1330 rixen
Overview
Contact
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for glaxosmithkline biologicals s.a. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 96 transactions, with a transaction quantity of 2285287.16 and a transaction weight of 83633.77.
Product description
SAMPLE FOR IN VITRO USE ONLY NOT FOR COMMERCIAL PURPOSE - ANALYSIS MATERIAL FOR ROTARIX (ROTA LIQULDE) ANTI-MOUSE IGG CONJUGATED WITH FLUORESCEIN - POLYCLONAL ANTIBODY FROMGOAT BIOLOGICAL REAGENT RWN0987A31 (U1124351184) QTY:- 3 PCS ( 2 ML )
Expand
Trade date
2026/05/15
B/L No.
——
Suppliers
glaxosmithkline biologicals s.a.
Buyers
m s glaxosmithkline pakistan ltd.
Product description
SAMPLE FOR IN VITRO USE ONLY NOT FOR COMMERCIAL PURPOSE - ANALYSIS MATERIAL FOR ROTARIX (ROTA LIQULDE) ROTAVIRUS VACCINE- FINAL CONTAINER -INTERNAL CONTROL CWN1826A01 (AROLA002A) QTY:- 3 PCS ( 1.500 UL )
Expand
Trade date
2026/05/15
B/L No.
——
Suppliers
glaxosmithkline biologicals s.a.
Buyers
m s glaxosmithkline pakistan ltd.
Product description
SAMPLE FOR IN VITRO USE ONLY NOT FOR COMMERCIAL PURPOSE - ANALYSIS MATERIAL FOR ROTARIX (ROTA LIQULDE) ROTAVIRUS LIQUID - FINAL CONTAINER- INTERNAL CONTROL - CWN1332A02 (EROLA001B) QTY:- 3 PCS ( 1.500 UL )
Expand
Trade date
2026/05/15
B/L No.
078871
Suppliers
glaxosmithkline biologicals s.a.
Buyers
ministerio de saludy
POLs
bruxelles (brussel)
PODs
aérea del callao
Supply area
Belgium
Purchas area
Peru
Weight
1246.731kg
Amount
1806880
Hs code
3002419000
Product tags
——
Product description
VACUNA HEPATITIS A PEDIÁTRICA, HAVRIX¿, S/M LOTES N° AHAVC226AB MFG:08.10.2025 EXP:30.09.2028; AHAVC216AD MFG:05.05.2025 EXP:30.04.2028 - USO MÉDICO - U/C: 1,964 PCK*100 VIALES HAVRIX PEDIATRIC VIAL 1DX100 EXPORT HEPATITIS A VACCINE - PEDIATRIC (1 DOSE) (1 DOSIS)= 196,400 DOSIS DE VACUNA CONTRA LA HEPATITIS A INYECTABLE,T.P.: 30 DÍAS - FECHA
Expand
Trade date
2026/05/08
B/L No.
——
Suppliers
glaxosmithkline biologicals s.a.
Buyers
m s glaxosmithkline pakistan ltd.
Product description
SAMPLE FOR IN VITRO USE ONLY NOT FOR COMMERCIAL PURPOSE ANALYSIS MATERIAL FOR ROTARIX (ROTA LIQULDE) ROTAVIRUS VACCINE- FINAL CONTAINER -INTERNAL CONTROL CWN0987A05 (AROTA363A) QTY:- 9 PCS ( 1 ML )
Expand
Trade date
2026/05/08
B/L No.
——
Suppliers
glaxosmithkline biologicals s.a.
Buyers
m s glaxosmithkline pakistan ltd.
Product description
SAMPLE FOR IN VITRO USE ONLY NOT FOR COMMERCIAL PURPOSE ANALYSIS MATERIAL FOR ROTARIX (ROTA LIQULDE) ROTAVIRUS MONOCLONAL ANTIBODY ANTI- VP7 FROM CELL LINE - BIOLOGICALREAGENT RWN0778A27 (23D05) QTY:- 3 PCS ( 1.000 UL )
Expand
Trade date
2026/05/08
B/L No.
——
Suppliers
glaxosmithkline biologicals s.a.
Buyers
m s glaxosmithkline pakistan ltd.
Product description
SAMPLE FOR IN VITRO USE ONLY NOT FOR COMMERCIAL PURPOSE ANALYSIS MATERIAL FOR ROTARIX (ROTA LIQULDE) TRYPSIN 0.25 % BIOLGICAL LIQUID BIOLOGICAL REAGENT RWN0987A32 (3108028) QTY:- 3 PCS ( 3.200 UL )
Expand
Trade date
2026/04/24
B/L No.
——
Suppliers
glaxosmithkline biologicals s.a.
Buyers
m s glaxosmithkline pakistan ltd.
5gsk vx marietta
united statesbuyer,they trade on 2026-06-09
2854.23%
>
+View All
Products
Total 281
ProductsTransactionsPerDetail
gh 25224.88%>
cod 19018.76%>
3m 15615.4%>
cf 14814.61%>
vial 12912.73%>
+View All
Hscode rank
Total 296
HSCode NameTransactionsPerDetail
HS 3002419018918.66%>
HS 300241900012011.85%>
HS 30024119605.92%>
HS 38229090414.05%>
HS 30021290353.46%>
+View All
Trading Area
Total 25
AreaTransactionsPerDetail
united states118017.52%>
colombia109616.28%>
russia101915.13%>
ukraine72610.78%>
vietnam5458.09%>
+View All
Port statistics
Total 47
Port NameTransactionsPerDetail
antwerp113416.84%>
bruxelles brussel2423.59%>
bruxelles1201.78%>
brussels1111.65%>
brussel bruxelles1001.49%>
+View All
glaxosmithkline biologicals s.a. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as gh,cod,3m.
According to the 52wmb.com global trade database, as of 2026-06-09, the company has completed 6734 international trades,
with its main trading regions covering united states,colombia,russia etc.
The core products include HS30024190,HS3002419000,HS30024119 etc,
often transported via antwerp,port bruxelles brussel, port bruxelles etc,
and its main trading partners are glaxosmithkline colombia s.a.,ооо вортэкс,gsk biologicals north america.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on glaxosmithkline biologicals s.a. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.